The VRBPAC said more research is needed to determine if additional safety precautions could be taken to mitigate the risk of VAERD with RSV vaccines. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
